Bob Harris, the beloved BBC radio presenter and music enthusiast, has begun a course of intravenous radiotherapy as part of his treatment for prostate cancer. The 80-year-old, known for his warm voice and deep knowledge of music, announced in April that his cancer had spread to his upper spine. As a result, he stepped down from hosting BBC Radio 2's Sounds Of The 70s and Radio 2 Country in June to focus on his health. Recently, he shared in an emotional message that his condition has progressed, leading to the start of targeted therapy aimed at slowing the disease's spread.
In a heartfelt Instagram post, Harris shared that he had been missing his radio programs but had spent the summer at home with family and friends. He mentioned that during this time, the cancer had been progressing, though he still feels physically well. The emotional moment came when he and his son, Miles, left the hospital after treatment, both brought to tears by the experience.
Despite the challenges, Harris urged others facing personal struggles to "never give in" and to fight with all their might. He thanked those who had sent messages of support and encouraged people to live each day to the fullest. Harris also confirmed his plans to perform at the Royal Albert Hall in December as part of Stand By Me: Bob Harris – A Celebration of Life In Music, a concert honoring his long and influential career.
Harris described stepping down from his radio roles as "one of the hardest decisions of my life." With nearly 56 years in broadcasting, he has worked across BBC Radio 1, BBC Six Music, and television, including hosting the iconic 1970s music program Old Grey Whistle Test. He is best known for championing genres like country, folk, Americana, and singer-songwriter music, introducing countless listeners to both emerging and established artists throughout his career.
Bob Harris Undergoes Cancer Treatment and Steps Down from BBC Radio 2 Shows
AI-rewritten from original reportingHow it works
bob-harrisprostate-cancerbbc-radiohealth-updatemusic-legendradiotherapy



